The message comes after Politico reported relationships between Mr. Azar and Mr. Grogan and other White House policy officials were wearing thin.
The Azar-Grogan op-ed recounts steps President Donald Trump and his administration have taken to address the ills of the U.S. healthcare system, including President Trump’s recent executive order on price transparency and a rule to expand health reimbursement arrangements, as well as expedited generic drug approvals and other drug pricing efforts.
“President Trump has promised a better vision: a healthcare system that treats you like a person, not a number,” the pair wrote. “He wants to hold providers and Big Pharma accountable to transparency and reasonable prices. We are working every day to protect American patients and deliver on the president’s vision.”
The Politico report, based on anonymous interviews with a dozen officials, alleged the tensions between HHS and the White House had stalled drug-pricing policy.
More articles on leadership and management:
Methodist Le Bonheur CEO: Reports misrepresent financial assistance programs
Newark Beth Israel, Children’s Hospital of New Jersey names board chair
Trump administration delays ‘conscience protection’ rule for healthcare workers
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
